Tissue kallikrein deficiency and renovascular hypertension in the mouse

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 5, 2009, Pages

  Griol Charhbili, Violaine ^a,e   Sabbah, Laurent ^b,c,d   Colucci, Juliana ^a   Vincent, Marie Pascale ^a   Baudrie, Véronique ^a,b   Laude, Dominique ^a,b   Elghozi, Jean Luc ^a,b,d   Bruneval, Patrick ^a,b,d   Picard, Nicolas ^a,b   Meneton, Pierre ^a,b   Alhenc Gelas, François ^a,b,d   Richer Giudicelli, Christine ^a,d,e  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL BROUSSAIS   (France)

^d BICÊTRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Kallikrein kinin system; Mice; Renin angiotensin system

Indexed keywords

KININ; RENIN; TISSUE KALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; GENE INACTIVATION; GENOTYPE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; KIDNEY BLOOD FLOW; MALE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

ANIMALS; BLOOD PRESSURE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HYPERTENSION, RENOVASCULAR; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; KININS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REGIONAL BLOOD FLOW; RENAL ARTERY; RENIN; TISSUE KALLIKREINS; VENTRICULAR REMODELING;

EID: 66149121007     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90411.2008     Document Type: Article

References (45)

1. Ader JL, Pollock DM, Butterfield MI, Arendshorst WJ. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 248: F396-F403, 1985.
2. Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 46: 932-936, 2005.
3. Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N, Bura-Riviere A, Laurent S, Alhenc-Gelas F, Jeunemaitre X. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest 115: 780-787, 2005. (Pubitemid 40322255)
4. Baudrie V, Laude D, Elghozi JL. Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice. Am J Physiol Regul Integr Comp Physiol 292: R904-R912, 2007. (Pubitemid 46207747)
5. Beierwaltes WH. Prostaglandin independence of kinin-stimulated renin release. Am J Physiol Renal Fluid Electrolyte Physiol 252: F794-F799, 1987.
6. 2 receptors. Circ Res 94: 1623-1629, 2004.
7. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Levy BI, Boulanger CM. Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ Res 88: 593-599, 2001. (Pubitemid 32275795)
8. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, Kuida H, Williams RR. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13: 3-8, 1989. (Pubitemid 19047274)
9. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1-80, 1992.
10. 1A receptor in the development of 2K1C hypertension. Hypertension 40: 735-741, 2002.
11. Cervenka L, Vaneckova I, Maly J, Horacek V, El-Dahr SS. Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor. J Hypertens 21: 1531-1538, 2003. (Pubitemid 36994133)
12. Chao J, Chao L. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases. Pharmacol Res 35: 517-522, 1997. (Pubitemid 27420467)
13. Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 90: 291-298, 2005. (Pubitemid 40685841)
14. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, Gavras H. Vasoactive potential of the B1-bradykinin receptor in normotension and hypertension. Circ Res 88: 275-281, 2001. (Pubitemid 32173750)
15. el-Dahr SS, Dipp S, Guan S, Navar LG. Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats. Am J Hypertens 6: 914-919, 1993.
16. Eng E, Veniant M, Floege J, Fingerle J, Alpers CE, Menard J, Clozel JP, Johnson RJ. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 7: 177-185, 1994. (Pubitemid 24079128)
17. Fujino T, Nakagawa N, Yuhki K, Hara A, Yamada T, Takayama K, Kuriyama S, Hosoki Y, Takahata O, Taniguchi T, Fukuzawa J, Hasebe N, Kikuchi K, Narumiya S, Ushikubi F. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. J Clin Invest 114: 805-812, 2004. (Pubitemid 39578739)
18. Galen FX, Devaux C, Atlas S, Guyenne T, Menard J, Corvol P, Simon D, Cazaubon C, Richer P, Badouaille G. New monoclonal antibodies directed against human renin: powerful tools for the investigation of the renin system. J Clin Invest 74: 723-735, 1984. (Pubitemid 14031007)
19. Girolami JP, Praddaude F, Ader JL, Tran Van T, Eche JP, Suc JM. Bilateral urinary kallikrein excretion in the Goldblatt hypertensive rat. Eur Heart J 4, Suppl G: 67-72, 1983. (Pubitemid 14210459)
20. Heo HJ, Yun MR, Jung KH, Lee JY, Park JY, Lee SJ, Bae SS, Lee WS, Kim CD. Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells. Life Sci 80: 1057-1063, 2007.
21. Iwai N, Yasui N, Naraba H, Tago N, Yamawaki H, Sumiya H. Klk1 as one of the genes contributing to hypertension in Dahl salt-sensitive rat. Hypertension 45: 947-953, 2005. (Pubitemid 40628942)
22. Jenzano JW, Coffey JC, Heizer WD, Lundblad RL, Scicli AG. The assay of glandular kallikrein and prekallikrein in human mixed saliva. Arch Oral Biol 33: 641-644, 1988.
23. Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension 28: 1064-1069, 1996. (Pubitemid 26415825)
24. 1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res 95: 523-531, 2004.
25. Madeddu P, Milia AF, Salis MB, Gaspa L, Gross W, Lippoldt A, Emanueli C. Renovascular hypertension in bradykinin B2-receptor knockout mice. Hypertension 32: 503-509, 1998. (Pubitemid 28429140)
26. Margolius HS, Geller R, De Jong W, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in rats with hypertension. Circ Res 30: 358-362, 1972.
27. Margolius HS, Horwitz D, Pisano JJ, Keiser HR. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res 35: 820-825, 1974.
28. Menard J, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90: 422-430, 1972.
29. Meneton P, Bloch-Faure M, Hagege AA, Ruetten H, Huang W, Bergaya S, Ceiler D, Gehring D, Martins I, Salmon G, Boulanger CM, Nussberger J, Crozatier B, Gasc JM, Heudes D, Bruneval P, Doetschman T, Menard J, Alhenc-Gelas F. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci USA 98: 2634-2639, 2001. (Pubitemid 32209534)
30. Navar LG, Ploth DW, Bell PD. Distal tubular feedback control of renal hemodynamics and autoregulation. Annu Rev Physiol 42: 557-571, 1980.
31. Nolly H, Carretero OA, Scicli G, Madeddu P, Scicli AG. A kallikrein-like enzyme in blood vessels of one-kidney, one clip hypertensive rats. Hypertension 16: 436-440, 1990. (Pubitemid 20338538)
32. Pellieux C, Sauthier T, Aubert JF, Brunner HR, Pedrazzini T. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice. J Hypertens 18: 1307-1317, 2000.
33. Picard N, Eladari D, El Moghrabi S, Planes C, Bourgeois S, Houillier P, Wang Q, Burnier M, Deschenes G, Knepper MA, Meneton P, Chambrey R. Defective ENaC processing and function in tissue kallikrein-deficient mice. J Biol Chem 283: 4602-4611, 2008.
34. Picard N, Van Abel M, Campone C, Seiler M, Bloch-Faure M, Hoenderop JG, Loffing J, Meneton P, Bindels RJ, Paillard M, Alhenc-Gelas F, Houillier P. Tissue kallikrein-deficient mice display a defect in renal tubular calcium absorption. J Am Soc Nephrol 16: 3602-3610, 2005. (Pubitemid 46211281)
35. Pietri L, Bloch-Faure M, Belair MF, Sanford LP, Doetschman T, Menard J, Bruneval P, Meneton P. Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-β2 gene. Exp Nephrol 10: 374-382, 2002. (Pubitemid 36151253)
36. Pons S, Fornes P, Hagege AA, Heudes D, Giudicelli JF, Richer C. Survival, haemodynamics and cardiac remodelling follow up in mice after myocardial infarction. Clin Exp Pharmacol Physiol 30: 25-31, 2003. (Pubitemid 36232739)
37. Pons S, Griol-Charhbili V, Heymes C, Fornes P, Heudes D, Hagege A, Loyer X, Meneton P, Giudicelli JF, Samuel JL, Alhenc-Gelas F, Richer C. Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice. Eur J Heart Fail 10: 343-351, 2008.
38. Richer C, Domergue V, Gervais M, Bruneval P, Giudicelli JF. Fluospheres for cardiovascular phenotyping genetically modified mice. J Cardiovasc Pharmacol 36: 396-404, 2000. (Pubitemid 30660472)
39. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989.
40. Sealey JE, Atlas SA, Laragh JH, Oza NB, Ryan JW. Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature 275: 144-145, 1978.
41. Suzuki S, Franco-Saenz R, Tan SY, Mulrow PJ. Direct action of rat urinary kallikrein on rat kidney to release renin. J Clin Invest 66: 757-762, 1980. (Pubitemid 10060944)
42. Trabold F, Pons S, Hagege AA, Bloch-Faure M, Alhenc-Gelas F, Giudicelli JF, Richer-Giudicelli C, Meneton P. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice. Hypertension 40: 90-95, 2002. (Pubitemid 34755985)
43. Wang T, Li H, Zhao C, Chen C, Li J, Chao J, Chao L, Xiao X, Wang DW. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Ther 11: 1342-1350, 2004. (Pubitemid 39213999)
44. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29: 1025-1030, 1997. (Pubitemid 27152476)
45. Yayama K, Wang C, Chao L, Chao J. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats. Hypertension 31: 1104-1110, 1998. (Pubitemid 28191504)